Ablative therapy for liver tumours
Authors:
Open Access
Abstract
Established ablative therapies for the treatment of primary and secondary liver tumours, including percutaneous ethanol injection, cryotherapy, and radiofrequency ablation, are discussed. Newer techniques such as magnetic resonance imaging guided laser interstitial thermal therapy of liver tumours has produced a median survival rate of 40.8 months after treatment. The merits of this newly emerging technique are discussed, together with future developments, such as focused ultrasound therapy, which holds the promise of non-invasive thermoablation treatment on an outpatient basis.Keywords
This publication has 51 references indexed in Scilit:
- Radiofrequency ablation in the treatment of hepatocellular carcinoma - a clinical viewpointJournal of Hepatology, 2000
- Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a ‘cooled-tip needle’. A preliminary clinical experienceEuropean Journal of Ultrasound, 1999
- Magnetic Resonance Imaging - Guided Abdominal Interventional Radiology: Laser-Induced Thermotherapy of Liver MetastasesEndoscopy, 1997
- Interventional Magnetic Resonance Imaging, Computed Tomography, and UltrasoundAcademic Radiology, 1995
- No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosisJournal of Hepatology, 1995
- Hepatectomy for liver metastasesBritish Journal of Surgery, 1993
- Monitoring of laser and freezinginduced ablation in the liver with T1‐weighted MR imagingJournal of Magnetic Resonance Imaging, 1992
- Interstitial Nd:YAG laser ablation in normal rabbit liver: Trial to maximize the size of laser‐induced lesionsLasers in Surgery and Medicine, 1992
- Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary resultsCancer, 1991
- Hepatic metastases from colorectal cancer: Resection or notBritish Journal of Surgery, 1988